Mainz BioMed N.V. | WebDisclosure

BRIEF

published on 10/01/2024 at 14:06, 1 month 20 days ago

Mainz Biomed's CEO Projects Substantial Growth and U.S. FDA Trials in 2025

Cancer Diagnostics Mainz Biomed CRC Screening FDA Trials Growth 2025
PRESS RELEASE

published on 10/01/2024 at 14:01, 1 month 20 days ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
Mainz Biomed CEO Guido Baechler shares plans for major growth and U.S. FDA trials in 2025, highlighting innovative cancer diagnostics and upcoming clinical developments

Growth Cancer Diagnostics CEO Statement Mainz Biomed FDA Trials
BRIEF

published on 09/18/2024 at 14:06, 2 months 3 days ago

Mainz Biomed Announces Petra Smeltzer Starke as Brand Ambassador

Cancer Screening Early Detection Brand Ambassador Biomed FDA Trial
BRIEF

published on 09/18/2024 at 14:06, 2 months 3 days ago

Mainz Biomed annonce Petra Smeltzer Starke comme ambassadrice de la marque

DÉTECTION PRÉCOCE Biomedical Ambassadrice De La Marque Dépistage Du Cancer Essai De La FDA
PRESS RELEASE

published on 09/18/2024 at 14:01, 2 months 3 days ago

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
Mainz Biomed N.V. announces Petra Smeltzer Starke as Brand Ambassador to focus on early detection awareness for colorectal cancer

Early Detection Mainz Biomed Colorectal Cancer Brand Ambassador Petra Smeltzer Starke
BRIEF

published on 09/04/2024 at 10:06, 2 months 17 days ago

Mainz Biomed Partners with Liquid Biosciences to Enhance Pancreatic Cancer Detection

AI Mainz Biomed Biomarkers Liquid Biosciences PancAlert
BRIEF

published on 09/04/2024 at 10:06, 2 months 17 days ago

Mainz Biomed s'associe à Liquid Biosciences pour améliorer la détection du cancer du pancréas

IA Biomarqueurs Mayence Biomed PancAlert Biosciences Liquides
PRESS RELEASE

published on 09/04/2024 at 10:01, 2 months 17 days ago

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
Mainz Biomed partners with Liquid Biosciences to leverage AI for biomarker selection in PancAlert, a next-gen pancreatic cancer detection test. Companies expand collaboration with promising results and plan to complete analysis by Q4 2024

AI Mainz Biomed Liquid Biosciences PancAlert Biomarker Selection
BRIEF

published on 07/25/2024 at 14:06, 3 months 27 days ago

Mainz Biomed Launches Enhanced ColoAlert to Improve Screening Efficiency

ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency DNA Stabilizing Buffer
BRIEF

published on 07/25/2024 at 14:06, 3 months 27 days ago

Mainz Biomed lance ColoAlert amélioré pour améliorer l'efficacité du dépistage

Cancer Colorectal Mayence Biomed ColoAlerte Efficacité Du Dépistage Tampon De Stabilisation De L'ADN

Published on 11/21/2024 at 16:30, 15 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 44 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 45 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 45 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 45 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 45 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 3 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 9 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 47 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 20 hours 38 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 25 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE

News